Publications by authors named "Finn Waagstein"

Claim this Profile
M
Multicentre, randomized, double-blind, prospective study on the effects of ImmunoAdSorptiOn on cardiac function in patients with Dilated CardioMyopathy (IASO-DCM): Rationale and design.
Marcus Dörr, Michael Böhm, Erland Erdmann, Stefan Groß, Amir-Abbas Mahabadi, Finn Waagstein

Eur J Heart Fail· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Awais Malik, Ravi Masson, Steven Singh, Wen-Chih Wu, Milton Packer, Finn Waagstein

J Am Coll Cardiol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The β-blocker uptitration in elderly with heart failure regarding biomarker levels: CIBIS-ELD substudy.
Natasa Cvetinovic, Nikola Sekularac, Stephan Von Haehling, Elvis Tahirovic, Simona Inkrot, Finn Waagstein

Biomark Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.
Phillip H Lam, Poonam Bhyan, Cherinne Arundel, Daniel J Dooley, Helen M Sheriff, Finn Waagstein

Clin Cardiol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolution of the Use of β-Blockers to Treat Heart Failure: A Conversation With Finn Waagstein, MD.
Finn Waagstein, John D Rutherford

Circulation· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.
Heinz-Peter Schultheiss, Cornelia Piper, Olaf Sowade, Finn Waagstein, Joachim-Friedrich Kapp

Clin Res Cardiol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Kevin Damman, John Kjekshus, John Wikstrand, John G F Cleland, Michel Komajda, Finn Waagstein

Eur J Heart Fail· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).
Svetlana Apostolovic, Dragana Stanojevic, Mitja Lainscak, Goetz Gelbrich, Ruzica Jankovic-Tomasevic, Finn Waagstein

Cardiol J· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
Vikas Bhatia, Navkaranbir S Bajaj, Kumar Sanam, Taimoor Hashim, Charity J Morgan, Finn Waagstein

Am J Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of Ventricular-Arterial Coupling in Elderly Patients with Heart Failure After Beta Blocker Therapy: Results from the CIBIS-ELD Trial.
Milica Dekleva, Jelena Suzic Lazic, Ivan Soldatovic, Simone Inkrot, Aleksandra Arandjelovic, Finn Waagstein

Cardiovasc Drugs Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial.
Ravi V Desai, Jason L Guichard, Marjan Mujib, Mustafa I Ahmed, Margaret A Feller, Finn Waagstein

Int J Cardiol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study.
Milica Dekleva, Hans-Dirk Düngen, Götz Gelbrich, Simone Incrot, Jelena Suzic Lazic, Finn Waagstein

Aging Clin Exp Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly.
Götz Gelbrich, Frank Edelmann, Simone Inkrot, Mitja Lainscak, Svetlana Apostolovic, Finn Waagstein

Int J Cardiol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial.
Goran Loncar, Stephan von Haehling, Elvis Tahirovic, Simone Inkrot, Meinhard Mende, Finn Waagstein

Clin Biochem· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.
Hans-Dirk Düngen, Svetlana Apostolovic, Simone Inkrot, Elvis Tahirovic, Agnieszka Töpper, Finn Waagstein

Eur J Heart Fail· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).
John J V McMurray, Peter Dunselman, Hans Wedel, John G F Cleland, Magnus Lindberg, Finn Waagstein

J Am Coll Cardiol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).
Sally C Inglis, John J V McMurray, Michael Böhm, Maria Schaufelberger, Dirk J van Veldhuisen, Finn Waagstein

Eur J Heart Fail· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence?
Elmir Omerovic, Finn Waagstein, Karl Swedberg

Eur J Heart Fail· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.
Paula K Lorgelly, Andrew H Briggs, Hans Wedel, Peter Dunselman, Ake Hjalmarson, Finn Waagstein

Eur J Heart Fail· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
John J V McMurray, John Kjekshus, Lars Gullestad, Peter Dunselman, Ake Hjalmarson, Finn Waagstein

Circulation· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
John G F Cleland, John J V McMurray, John Kjekshus, Jan H Cornel, Peter Dunselman, Finn Waagstein

J Am Coll Cardiol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Digoxin and Reduction in Mortality and Morbidity in Heart Failure.
Ali Ahmed, Finn Waagstein

Int J Cardiol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
Jalal K Ghali, John Wikstrand, Dirk J Van Veldhuisen, Björn Fagerberg, Sidney Goldstein, Finn Waagstein

J Card Fail· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.
Hans Wedel, John J V McMurray, Magnus Lindberg, John Wikstrand, John G F Cleland, Finn Waagstein

Eur J Heart Fail· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria.
Elmir Omerovic, Gerhard Brohall, Markus Müller, Truls Råmunddal, Göran Matejka, Finn Waagstein

Ther Clin Risk Manag· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis